The Comparison of 2-Chlorodeoxyadenosine (2-Cd A) in Combination with Interferon α (IFN α) or Interferon γ (IFN γ) on Granulocyte-Macrophage Progenitor Cells (CFU-GM) and Clonogenic Blasts in (CFU-L) In Vitro Cultures

References

• Piro L. D. 2-chlorodeoxyadenosine treatment of lymphoid malignancies. Blood 1992; 80: 843–845
   PubMedGoogle Scholar
• Lauria F. 2-Chlorodeoxyadenosine, “novel” agent in the treatment of both lymphoid and myeloid malignancies. Haematologica 1992; 77: 443–445
   PubMedGoogle Scholar
• Santana V. M., Mirro J., Kearns C., Schell M. J., Crom W. Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. J. Clin. Oncol 1992; 10: 364–370
   PubMed Web of Science ®Google Scholar
• Saven A., Lemon R., Figueroa M., Kosty M., Ellison D. Complete hematologic remissions in stable phase. Ph–chromosome positive, chronic myeloid leukemia (CML) following 2-chlorodeoxyadenosine (2-CdA). Proc. Am. Soc. Clin. Oncol 1993; 310, (Abst. No 1022)
   PubMedGoogle Scholar
• Goldstein D., Laszlo J. Interferon in cancer: From imagination to inrferon. Cancer Res 1986; 46: 4315–4329
   PubMed Web of Science ®Google Scholar
• Wadler S., Schwartz E. L. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies. A review. Cancer Res 1990; 50: 3473–3486
   PubMed Web of Science ®Google Scholar
• Dvilansky A., Kafka M., Nathan J. Mechanisms of interaction between interferon gamma and antineoplastic agents on growth and differentiation of leukemic cells: a review. Leuk. Lymph 1992; 6: 469–477
   Web of Science ®Google Scholar
• Robak T., Korycka A., Góra-Tybor J. The interaction of 2-chlorodeoxydenosine (2-CdA) and interferon α (IFNα) on normal and myeloid leukemia hematopoiesis in vitro. Leuk. Res 1994; 18: 275–281
   PubMed Web of Science ®Google Scholar
• Iscove N. N., Sieber F., Winterhalter K. H. Erythroid colony formation in culture of mouse and human bone marrow. Analysis of the requirement chromatography on agarose-cancanavalin A. Am. J. Cell. Physiol 1974; 83: 303–320
   Google Scholar
• Hibbin J. A., Nioku O. S., Matutes E., Lewis S. M., Goldman J. M. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br. J. Haematol 1984; 57: 495–503
   PubMed Web of Science ®Google Scholar
• Buick R. N., Till J. E., McCulloch E. A. Colony assay for proliferative blast cells circulation in myeloid leukemia. Lancet 1977; 1: 862–863
   PubMed Web of Science ®Google Scholar
• Korycka A., Robak T. The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukemic blasts (CFU-L) in the cultures in vitro. Arch. Immunol. Ther. Exp 1991; 39: 495–500
   PubMedGoogle Scholar
• Minden M. D., Buick R. N., McCulloch E. A. Separation of blast cells and T-lymphocyte progenitors in the blood of patients with acute myeloid leukemia. Blood 1979; 54: 186–195
   PubMed Web of Science ®Google Scholar
• Kazimierczuk Z., Vilpo J., Hildebrand C., Wright G. Synthesis and cytotoxicity of deoxyadenosine analogues: isomer distribution in the sodium salt glycosylation of 2,6-disubstitutes purines. J. Med. Chem 1990; 33: 1683–1687
   PubMed Web of Science ®Google Scholar
• Kristensen J., Nygren P., Liliemark J., Fridborg H., Kiliander A., Simonsson B., Oberg G., Larsson R. Interactions between Cladribine (2-CdA) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myeloid leukemia. Leukemia 1994; 8: 1712–1717
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Talpaz M., Kantarjian H., Walters R., Saks S., Trujillo J. M., Gutterman J. U. Therapy of chronic myeloid leukemia with recombinant interferon-γ. Blood 1987; 70: 943–947
   PubMed Web of Science ®Google Scholar
• Mahmoud H. H., Pui G. H., Kennedy W., Saffe H. S., Crist W. M., Murphy S. B. Phase I study of recombinant human interferon gamma in children with relapsed acute leukemia. Leukemia 1992; 6: 1181–1184
   PubMed Web of Science ®Google Scholar
• Petzer A. L., Bilgeri R., Zihan U., Hann M., Geisen F. H., Pragnell J., Bransteiner H., Konwalinka G. Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid and T-lymphocytic colony growth. Blood 1991; 78: 2583–2587
   PubMed Web of Science ®Google Scholar
• Bryson H. M., Sorkin E. M. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in hematological malignancies. Drugs 1993; 46: 872–894
   PubMed Web of Science ®Google Scholar
• Nara N. Combined effect of interferon-γ and tumor necrosis factor-α causing suppression of leukemic blast progenitors in acute myeloid leukemia. Leuk. Lymph 1993; 10: 201–207
   PubMed Web of Science ®Google Scholar
• Koike K., Ma F., Shiohara M., Kubo T., Takagi M., Amano Y., Nakahata T., Komiyama A. Interferon gamma inhibits proliferation but not commitment of murine graulocyte-macrophage progenitors. J. Cell. Physiol 1992; 153: 528–533
   PubMed Web of Science ®Google Scholar
• Shiohara M., Koike K., Nakahata T. Synergism of interferon-γ and stem cell factor on the development of murine hematopoietic progenitors in serum free culture. Blood 1993; 81: 1435–1441
   PubMed Web of Science ®Google Scholar
• Mamus S. W., Beck-Schroder S., Zanjani E. D. Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T-lymphocytes. J. Clin. Invest 1985; 75: 1496–1503
   PubMed Web of Science ®Google Scholar
• Delforge A., Vandenplas B., Lagneaux L., Loos M., Bron D., Debusscher L., Strykmans P. Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid leukemic progenitors. Eur. J. Haematol 1990; 44: 307–311
   PubMed Web of Science ®Google Scholar
• Todd P. A., Goa K. L. Interferon-γ-lb. A review of its pharmacology and therapeutic potential in chronic granulomatous disease. Drugs 1992; 43: 111–122
   PubMed Web of Science ®Google Scholar
• Morikawa K., Fan D., Denkins Y. M., Lewis B., Gutterman J. U., Walker S. M., Fidler I. J. Mechanism of combined effects of γ-interferon and 5-fluorouracil on human colon cancer implanted into nude mice. Cancer Res 1989; 49: 799–805
   PubMed Web of Science ®Google Scholar
• Lienard D., Ewalenko P., Delmotte J. J., Renard N., Lejeune F. J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of limbs melanoma and sarcoma. J. Clin. Oncol 1992; 10: 52–60
   PubMed Web of Science ®Google Scholar
• Kafka M., Nathan J., Dvilansky A. New combination of 5-Fluorouracil and interferon-γ effective against human myeloid leukemia in vitro. Anticancer Res 1989; 9: 1037–1040
   PubMed Web of Science ®Google Scholar
• Kafka M., Dvilansky A., Nathan J. Mechanism of interaction between interferon-γ and antineoplastic agents on the differentiation of HL-60 promyelocyte cells. Exp. Hematol 1990; 18: 153–158
   PubMed Web of Science ®Google Scholar
• Robertson L. E., Chubb S., Meyn R. E., Stoy M., Ford R., Hittelman W. N., Plunket W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'deoxyadenosine and 9–D-arabinosyl-2-fluoroadenine. Blood 1993; 81: 143–150
   PubMed Web of Science ®Google Scholar
• Faltynek C. R. Opposite effects of recombinant interferon-α and deoxycoformycin on adenosine deaminase in the Dandi B lymphoblastoid cell line. Blood 1988; 71: 59–64
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Cazzola M., Ganser A., Bergamachi G., Pedrazzoli P., Hoelzer D., Ascari E. Synergistic antiproliferative effect of recombinant interferon-γ with recombinant interferon-α on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E and CFU-E). Blood 1988; 73: 1293–1299
   Google Scholar
• Ishii Y., Tsukagoshi S. The synergistic effect of human recombinant interferon alpha 2a in combination with interferon gamma and the induction of interferon alpha 2a receptor by interferon gamma. J. Pharmacobiodyn 1989; 12: 299–304
   PubMedGoogle Scholar
• Wandl U. B., Ogalka B., Kloke O., Nagel-Hiemke M., Moritz T., Niederle N. Treatment of chronic myelogenous leukemia with different cytokines. Semin. Oncol 1992; 19: 80–86, (Supp. 4)
   PubMedGoogle Scholar